To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

October 30, 2024

Study Completion Date

December 30, 2024

Conditions
Preterm BirthPreterm LaborIntra-amniotic InfectionAmniocentesis Affecting Fetus or Newborn
Interventions
DRUG

Steroid Drug

Steroids doses will be optimized in the intervention group according the risk based on predictive models

DRUG

Tocolytic Agents

Tocolysis duration will be optimized in the intervention group according the risk based on predictive models

Trial Locations (1)

08828

Fundació Recerca Biomèdica Clínica, Barcelona

All Listed Sponsors
collaborator

Hospital Vall d'Hebron

OTHER

collaborator

Hospital Universitario La Fe

OTHER

collaborator

Hospital Universitario La Paz

OTHER

collaborator

Hospital Universitario 12 de Octubre

OTHER

collaborator

Consorci Sanitari de Terrassa

OTHER

collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

collaborator

Hospital Universitario Puerta del Mar

OTHER

collaborator

Hospital Sant Joan de Deu

OTHER

collaborator

Germans Trias i Pujol Hospital

OTHER

collaborator

University Hospital Virgen de las Nieves

OTHER

collaborator

Hospital Clínico Universitario Lozano Blesa

OTHER

collaborator

Parc Taulí Hospital Universitari

OTHER

collaborator

Complexo Hospitalario Universitario de A Coruña

OTHER

collaborator

Hospital Son Llatzer

OTHER

collaborator

Hospital Universitari Joan XXIII de Tarragona.

OTHER

collaborator

Hospital Universitario de Torrejón

UNKNOWN

lead

Fundacion Clinic per a la Recerca Biomédica

OTHER